Semafore Pharmaceuticals

February 7, 2012

Drug Development Spotlight: The mTOR’s New Clothes?

November 22, 2010 By MD Becker Partners Leave a Comment

MD Becker Partners' Life Science Digest: Drug Development Spotlight - The mTOR’s New Clothes?

In 1837, Hans Christian Andersen authored a short tale titled The Emperor’s New Clothes. The main character, so enamored by his appearance and his clothing that he had a different suit for every hour of the day, was swindled by a pair of weavers purporting that they could create clothing from a magical fabric that [...]

Filed Under: Articles Tagged With: AEterna Zentaris, AEZS, Afinitor, Akt, American Society of Clinical Oncology, American Society of Hematology, ARIA, ARIAD Pharmaceuticals, ASCO, ASH, Astellas Pharma, AstraZeneca plc, AZD8055, AZN, BAY80-6946, Bayer, BAYRY.PK, BEZ235, BGT226, BKM120, BYL719, CAL-101, Calistoga Pharmaceuticals, Emperor's New Clothes, everolimus, EXEL, Exelixis, GDC-0980, GDC0941, GlaxoSmithKline, GSK, GSK2126458, Hans Christian Andersen, INK128, Intellikine, Keryx Biopharmaceuticals, KRAS, MAPK, Merck, MK2206, MRK, mTOR, mTORC1, mTORC2, Novartis AG, NVS, Oncothyreon, ONTY, OSI-027, Perifosine, PF-04691502, PFE, Pfizer, PGNX, phosphatidylinositol 3-kinase, pi3k, PIK3CA, PKI-587, prodrug, Progenics Pharmaceuticals, PX-866, rapamycin, RHHBY.PK, Ridaforolimus, Roche Holding AG, Sanofi-Aventis, Semafore Pharmaceuticals, SF1126, SNY, Temsirolimus, Torisel, Triciribine, VioQuest Pharmaceuticals, VOQP.PK, XL147, XL765

Biotech Baker’s Dozen to Watch at Hematology Meeting

November 29, 2009 By MD Becker Partners 2 Comments

The 51st American Society of Hematology [ASH] Annual Meeting will take place December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. This is the premier event for the hematology industry, attracting more than 20,000 hematologists and other health-care professionals. In this regard, Celgene Corporation (CELG) recently announced that data from [...]

Filed Under: Articles Tagged With: AEterna Zentaris, AEZS, Allos Therapeutics, ALTH, American Society of Hematology, ARIA, ARIAD Pharmaceuticals, Calistoga Pharmaceuticals, CELG, Celgene, chemotherapeutics, CYCC, Cyclacel Pharmaceuticals, Facet Biotech, FACT, GENT, Gentium SPA, HDAC inhibitors, IMGN, ImmunoGen, KaloBios Pharmaceuticals, kerx, Keryx Biopharmaceuticals, kinase inhibitors, monoclonal antibodies, nucleoside analogues, ONXX, Onyx Pharmaceuticals, PCYC, Pharmacyclics, pi3k, proteasome inhibitors, sapacitabine, Seattle Genetics, Semafore Pharmaceuticals, SGEN, small modular immunopharmaceuticals, SNSS, Sunesis Pharmaceuticals, TRBN, Trubion Pharmaceuticals